Lab marker
IGF-1
Insulin-like growth factor 1 · Somatomedin C
A growth-hormone-axis proxy with a U-shaped mortality relationship: both very high and very low values associate with elevated risk.
What it measures
Insulin-like growth factor 1, primarily hepatic-derived under growth hormone stimulation. Captures integrated GH-axis activity over hours-to-days. Reported in ng/mL or nmol/L. Strongly age-dependent; declines from peak in adolescence through old age.
Reference context
2 guideline sources
IGF-1 declines roughly 1–2% per year through adulthood. Very high values may suggest acromegaly; very low values in a symptomatic adult may suggest GH deficiency. Mid-normal-for-age values appear lowest-mortality in most cohort meta-analyses.
Population context: consult guideline targets below
Mechanism
Why moving this marker matters
IGF-1 mediates many of GH's anabolic effects on tissues: muscle, bone, organs. The longevity literature presents an apparent paradox: very low IGF-1 (Laron syndrome, calorie restriction) is associated with reduced cancer incidence and extended lifespan in animal models, while in humans, both very low and very high IGF-1 are associated with elevated mortality (U-shaped relationship; Burgers 2011 meta-analysis, Rahmani 2022 meta-analysis).
Guideline targets
What major guidelines recommend
Age- and sex-adjusted reference (lab-specific)
Most labs report results as z-score or % of age-matched reference. Track against percentile rather than absolute value.
Approximate adult reference (lab-dependent)
Ages 30–40: ~120–260 ng/mL; 40–60: ~80–230 ng/mL; 60+: ~60–200 ng/mL
How to measure
The test, where to get it, when to repeat
Method
Standard blood draw. Time of day modestly affects readings; consistent timing useful for trend monitoring. Random measurement is acceptable for screening; diurnal variation is far less than for GH itself.
Where
GP request (often only when GH disorder suspected) or comprehensive private panel.
Typical cost
€30–60 private.
Fasting
Not required
When to test
Endocrine Society 2011 (adult GH deficiency)
Indicated when GH excess (acromegaly) or deficiency is suspected. Routine population screening of healthy adults not recommended.
Where to test
Independent labs offering this test
No direct-to-consumer lab currently in our directory for this marker. Your GP can request it on a standard panel.
Context
Reading the numbers
IGF-1 declines roughly 1–2% per year through adulthood. Very high values may suggest acromegaly; very low values in a symptomatic adult may suggest GH deficiency. Mid-normal-for-age values appear lowest-mortality in most cohort meta-analyses.
Caveats
Acute illness, malnutrition, severe insulin deficiency, and hepatic dysfunction all lower IGF-1 independently of GH-axis status. Oestrogen therapy lowers; testosterone replacement slightly raises.
Practices
What's been shown to influence this marker
Severe protein or energy restriction lowers IGF-1, and adequate protein restores it (Thissen 1994 review); within usual intakes the effect of protein on IGF-1 appears small.
CautionHabitAdequate protein (1.2–1.6 g/kg)
Trials of extra protein show small gains in lean mass in older adults, not clear strength gains. Target used here: 1.2–1.6 g/kg body weight.
Why
The RDA is 0.8 g/kg. Small trials in older adults are consistent with 1.2 g/kg or more, but do not compare the 1.2–1.6 range against lower intake. Most trials test protein supplements alongside resistance training; one meta-regression found no further fat-free mass gain once total intake passed about 1.6 g/kg/day, with smaller effects at older ages. Distribute across meals.
Slot in your day
How to do it
How
Calculate target. Track for a week to see baseline. Add eggs, fish, dairy, legumes, or whey to meals to close the gap.
Sticking with it
Anchor 30g of protein at breakfast. It's the meal most people miss.
Markers this may influence
Evidence
Wirth 2020 J Nutr meta-analysis (65 RCTs, n=2,907 healthy adults): protein supplementation raised lean body mass by 0.46 kg in older adults, but not handgrip or leg press strength. Morton 2018 Br J Sports Med meta-analysis (49 RCTs, n=1,863) found no further fat-free mass gain from resistance training once total intake passed about 1.6 g/kg/day, with smaller effects at older ages. Trials mostly tested supplements rather than a 1.2-1.6 g/kg target.
GRADE certainty: Low — rated by Healicus using the GRADE method (indirect: trials mostly test protein supplements, largely with resistance training; small effects; strength results inconsistent)
- Morton RW et al., A systematic review, meta-analysis and meta-regression of the effect of protein supplementation on resistance training-induced gains in muscle mass and strength in healthy adults, Br J Sports Med 2018
- Cermak NM et al., Protein supplementation augments the adaptive response of skeletal muscle to resistance-type exercise training: a meta-analysis, Am J Clin Nutr 2012
- Wirth J et al., The Role of Protein Intake and its Timing on Body Composition and Muscle Function in Healthy Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials, J Nutr 2020
- Gielen E et al., Nutritional interventions to improve muscle mass, muscle strength, and physical performance in older people: an umbrella review of systematic reviews and meta-analyses, Nutr Rev 2021
- Lin CC et al., Effects of adequate dietary protein with whey protein, leucine, and vitamin D supplementation on sarcopenia in older adults: An open-label, parallel-group study, Clin Nutr 2021
- Weijs PJM, Wolfe RR, Exploration of the protein requirement during weight loss in obese older adults, Clin Nutr 2016
- McKendry J et al., The effects of whey, pea, and collagen protein supplementation beyond the recommended dietary allowance on integrated myofibrillar protein synthetic rates in older males: a randomized controlled trial, Am J Clin Nutr 2024
- Spahits H et al., Impact of a high-protein diet with and without strength training over 17 weeks on the plasma metabolome in older adults, Age Ageing 2026
HabitResistance training
2 sessions/week, the amount WHO advises from age 65; trials in adults 60+ show gains in muscle mass and strength.
Why
Sarcopenia (age-related muscle loss) starts in the third decade and accelerates from 50. A network meta-analysis of 151 randomised trials in adults 60+ found resistance training improved lean body mass, muscle size, lower-limb strength and timed walking and mobility tests. WHO advises muscle-strengthening on two or more days a week for adults 65 and over.
Slot in your day
How to do it
How
Six compound movements (squat, hinge, push, pull, carry, rotate), 2–3 sets each, 2× per week. Bodyweight is fine to start; progress to weighted as form solidifies.
Ideal for
Adults over 60, where the trials are; younger adults can reasonably start earlier.
Sticking with it
Two fixed weekday slots beat 'three sessions whenever'. The schedule is the programme.
Markers this may influence
Evidence
Radaelli 2025 Sports Med systematic review and network meta-analysis (151 RCTs, n=6,306): resistance training in adults 60+ improved lean body mass, muscle size, lower-limb strength and timed function tests. In Villareal 2017 N Engl J Med (RCT, n=160, dieting obese older adults), resistance training limited lean-mass loss to 2%, versus 5% with aerobic training. WHO advises muscle strengthening on two or more days a week from age 65.
GRADE certainty: Moderate — rated by Healicus using the GRADE method
- Radaelli R et al., Effects of Resistance Training Volume on Physical Function, Lean Body Mass and Lower-Body Muscle Hypertrophy and Strength in Older Adults: A Systematic Review and Network Meta-analysis of 151 Randomised Trials, Sports Med 2025
- Villareal DT et al., Aerobic or Resistance Exercise, or Both, in Dieting Obese Older Adults, N Engl J Med 2017
- Mertz KH et al., The effect of daily protein supplementation, with or without resistance training for 1 year, on muscle size, strength, and function in healthy older adults: A randomized controlled trial, Am J Clin Nutr 2021
- Liao CD et al., Effects of protein supplementation combined with resistance exercise on body composition and physical function in older adults: a systematic review and meta-analysis, Am J Clin Nutr 2017
- Valenzuela PL et al., Effects of physical exercise on physical function in older adults in residential care: a systematic review and network meta-analysis of randomised controlled trials, Lancet Healthy Longev 2023
- WHO guideline (2020): WHO Guidelines on Physical Activity and Sedentary Behaviour (2020)
See also
Related markers
Take to your physician
Worth discussing
- If your value is markedly outside the age-adjusted range, whether further endocrine workup is warranted (GH stimulation testing for low values; pituitary MRI for very high values).
- Why mid-normal-for-age is the working interpretation in longevity contexts.
- How to interpret IGF-1 alongside other markers rather than in isolation.
Sources
Cited literature
- [1]Burgers et al., Meta-analysis and dose-response metaregression: circulating insulin-like growth factor I (IGF-I) and mortality (J Clin Endocrinol Metab)(2011)
- [2]Rahmani et al., Association between IGF-1 levels ranges and all-cause mortality: a meta-analysis (Aging Cell)(2022)
- [3]Molitch et al., Endocrine Society Clinical Practice Guideline, Evaluation and treatment of adult growth hormone deficiency(2011)
- [4]Thissen et al., Nutritional regulation of the insulin-like growth factors (Endocr Rev)(1994)
Last reviewed October 2026
Keep reading
← Previous
Lab marker
uACR
The other half of CKD staging: KDIGO weighs urinary albumin co-equally with eGFR, and most adults never have it tested.
Next →
Lab marker
Morning cortisol
The body's master stress hormone, read at its daily peak. A precise clinical tool for adrenal disease, and a contested research window onto chronic stress.